Print Page  Close Window
8-K
PARATEK PHARMACEUTICALS, INC. filed this Form 8-K on 01/04/2019
Entire Document
 

Slide 34

*S. anginosus group consists of: S. anginosus, S. intermedius, and S. constellatus. MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; VSE, vancomycin-susceptible enterococci. Clinical Success at PTE by Baseline Pathogen (OASIS-1) Highly Effective Across Key Gram (+) Skin Pathogens Omadacycline (N=228) Linezolid (N=227) Baseline Pathogen N1 Favorable Response n (%) N1 Favorable Response n (%) Staphylococcus aureus 156 130 ( 83.3) 151 126 ( 83.4) MRSA 69 57 ( 82.6) 50 43 ( 86.0) MSSA 88 74 ( 84.1) 102 84 ( 82.4) Streptococcus anginosus group 47 36 ( 76.6) 37 26 ( 70.3) Streptococcus pyogenes 11 8 ( 72.7) 18 16 ( 88.9) Enterococcus faecalis (VSE) 10 9 ( 90.0) 13 12 ( 92.3) *10 or More Isolates for Omadacycline